Out of the Crisis #5, ANA Therapeutics: a possible COVID-19 treatment and prophylactic
Startup Lessons Learned
MAY 27, 2020
51:36) Scientific background on niclosamide, what we know about how it works to stop viral replication. (52:48) And while I didn't spend a great deal of time in research, I somehow pivoted into IP licensing, which led me to meet Nadja and we founded YourChoice Therapeutics together, and that's what led to the genesis of ANA Therapeutics.
68 
Let's personalize your content